Drug Type Small molecule drug |
Synonyms JIN A03 |
Target |
Action inhibitors |
Mechanism Tyrosine kinase inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| EGFR ex20ins mutation in non-small cell lung cancer | Preclinical | South Korea | 06 Feb 2023 |





